- Home
- UROY vs NGNE Comparison
UROY vs NGNE Comparison
Compare UROY & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UROY
- NGNE
- Stock Information
- Founded
- UROY 2017
- NGNE 2003
- Country
- UROY Canada
- NGNE United States
- Employees
- UROY N/A
- NGNE N/A
- Industry
- UROY
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- UROY
- NGNE Health Care
- Exchange
- UROY Nasdaq
- NGNE Nasdaq
- Market Cap
- UROY 294.0M
- NGNE 352.4M
- IPO Year
- UROY N/A
- NGNE N/A
- Fundamental
- Price
- UROY $2.13
- NGNE $22.64
- Analyst Decision
- UROY Strong Buy
- NGNE Strong Buy
- Analyst Count
- UROY 2
- NGNE 6
- Target Price
- UROY $5.60
- NGNE $60.80
- AVG Volume (30 Days)
- UROY 2.4M
- NGNE 481.6K
- Earning Date
- UROY 12-12-2024
- NGNE 11-18-2024
- Dividend Yield
- UROY N/A
- NGNE N/A
- EPS Growth
- UROY 256.61
- NGNE N/A
- EPS
- UROY 0.03
- NGNE N/A
- Revenue
- UROY $27,478,292.00
- NGNE $925,000.00
- Revenue This Year
- UROY N/A
- NGNE N/A
- Revenue Next Year
- UROY $72.53
- NGNE N/A
- P/E Ratio
- UROY $82.15
- NGNE N/A
- Revenue Growth
- UROY 31.26
- NGNE N/A
- 52 Week Low
- UROY $1.86
- NGNE $14.41
- 52 Week High
- UROY $3.76
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- UROY 31.97
- NGNE 40.23
- Support Level
- UROY $2.42
- NGNE $21.34
- Resistance Level
- UROY $2.70
- NGNE $25.35
- Average True Range (ATR)
- UROY 0.14
- NGNE 2.14
- MACD
- UROY -0.03
- NGNE 0.88
- Stochastic Oscillator
- UROY 10.94
- NGNE 38.64
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.